Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design

Core Insights - Twist Bioscience Corporation announced the publication of a peer-reviewed paper in Science, focusing on biosecurity screening practices in AI-assisted protein design, led by Microsoft and involving a consortium of experts [1][2][3] Company Overview - Twist Bioscience is a mid-cap growth and value biotech company that emphasizes biosecurity innovation and leadership in policy engagement and technical solutions [1][2] - The company has developed stringent biosecurity screening methods alongside its commercial offerings, ensuring robust practices for known proteins and sequences [3] Industry Context - The publication highlights the need for iterative improvement and cross-industry collaboration in biosecurity screening as AI technologies evolve [2][3] - The study indicates that AI-designed protein variants could evade standard biosecurity screening, necessitating the development of improved detection protocols [3] Collaborative Efforts - Twist's participation in the initiative with Microsoft and other organizations demonstrates a proactive approach to safeguarding public health and advancing responsible research [2][3] - The coordinated red-teaming exercise led to the creation of novel strategies that enhance the accuracy of screening engineered protein sequences [3]